These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 54318)

  • 1. Separation of human antihemophilic factor (AHF, factor VIII) from fibrinogen by means of defibrase.
    Lopaciuk S; Latallo ZS; Bykowska K; Daszynski J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(6):671-8. PubMed ID: 54318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Isolation and some properties of factor VIII (antihemophilic factor)].
    Bykowska K; Lopaciuk S; Michalski R
    Acta Haematol Pol; 1976 OCT-DEC; 7(4):283-92. PubMed ID: 998139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of antihemophilic factor and fibronectin from human plasma cryoprecipitate.
    Horowitz B; Lippin A; Chang MY; Shulman RW; Vandersande J; Stryker MH; Woods KR
    Transfusion; 1984; 24(4):357-62. PubMed ID: 6431661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of antihemophilic factor from indated plasma.
    Wickerhauser M
    Transfusion; 1976; 16(4):345-50. PubMed ID: 951729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic studies of antihemophilic factor (AHF, factor VIII). V. Immunologic properties of AHF subunits produced by salt dissociation.
    Rick ME; Hoyer LW
    Blood; 1973 Nov; 42(5):737-47. PubMed ID: 4200955
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the purification of antihemophilic factor (factor VIII). II. Separation of partially purified antihemophilic factor by gel filtration of plasma.
    Ratnoff OD; Kass L; Lang PD
    J Clin Invest; 1969 May; 48(5):957-62. PubMed ID: 5780204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the nature of antihemophilic factor (factor VIII). Further evidence relating the AHF-like antigens in normal and hemophilic plasmas.
    Bennett B; Forman WB; Ratnoff OD
    J Clin Invest; 1973 Sep; 52(9):2191-7. PubMed ID: 4199413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of the separation of fibrinogen and antihemophilic factor (AHF) in canine, porcine, and human plasmas.
    WAGNER RH; RICHARDSON BA; BRINKHOUS KM
    Thromb Diath Haemorrh; 1958 Apr; 1(1):1-8. PubMed ID: 13569420
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography.
    Orthner CL
    J Lab Clin Med; 1984 Nov; 104(5):816-28. PubMed ID: 6436416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein content and factor VIII complex in untreated, treated and monoclonal factor VIII concentrates.
    Morfini M; Rafanelli D; Filimberti E; Cinotti S; Piazza E; Longo G; Rossi Ferrini P
    Thromb Res; 1989 Oct; 56(2):169-78. PubMed ID: 2515605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro characterization of various factor VIII concentrates.
    Yoshioka A; Shima M; Nishino M; Yoshikawa N; Fukui H
    Arzneimittelforschung; 1987 Jul; 37(7):753-6. PubMed ID: 3118888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the snake venom batroxobin (Defibrase) on the degree of inflammatory reactions and on fibrinogen and C-reactive protein levels in rats.
    Hirschelmann R; Schade R; Lange U; Bekemeier H
    Pharmazie; 1989 Jul; 44(7):505-6. PubMed ID: 2813493
    [No Abstract]   [Full Text] [Related]  

  • 14. Heckathorn's disease: variable functional dificiency of antihemophilic factor (factor VIII).
    Ratnoff OD; Lewis JH
    Blood; 1975 Aug; 46(2):161-73. PubMed ID: 1139038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of a bovine spongiform encephalopathy-derived agent over ion-exchange chromatography used in the preparation of concentrates of fibrinogen and factor VIII.
    Foster PR; Griffin BD; Bienek C; McIntosh RV; MacGregor IR; Somerville RA; Steele PJ; Reichl HE
    Vox Sang; 2004 Feb; 86(2):92-9. PubMed ID: 15023177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunofluorescent localization of antihemophilic factor antigen and fibrinogen in human renal diseases.
    Hoyer JR; Michael AF; Hoyer LW
    J Clin Invest; 1974 May; 53(5):1375-84. PubMed ID: 4596507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of defibrase in treatment of acute cerebral infarction.
    Guo Y; Zuo YF; Wang QZ; Tang BS; Li FK; Sun Y
    Chin Med J (Engl); 2006 Apr; 119(8):662-8. PubMed ID: 16635411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The preparation and some properties of a clinically useful, high purity, human antihemophilic factor (AHF).
    Johnson AJ; Newman J; Howell MB; Puszkin S
    Bibl Haematol; 1968; 29():1109. PubMed ID: 5700306
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunologic studies of antihemophilic factor (AHF, factor VIII). IV. Radioimmunoassay of AHF antigen.
    Hoyer LW
    J Lab Clin Med; 1972 Dec; 80(6):822-33. PubMed ID: 4634503
    [No Abstract]   [Full Text] [Related]  

  • 20. Affinity purification of plasma proteins: characterization of six affinity matrices and their application for the isolation of human factor VIII.
    te Booy MP; Riethorst W; Faber A; Over J; König BW
    Thromb Haemost; 1989 Apr; 61(2):234-7. PubMed ID: 2501896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.